Literature DB >> 12885252

Differential interaction of GRK2 with members of the G alpha q family.

Peter W Day1, Christopher V Carman, Rachel Sterne-Marr, Jeffrey L Benovic, Philip B Wedegaertner.   

Abstract

Regulators of G protein signaling (RGS) proteins bind to active G alpha subunits and accelerate the rate of GTP hydrolysis and/or block interaction with effector molecules, thereby decreasing signal duration and strength. RGS proteins are defined by the presence of a conserved 120-residue region termed the RGS domain. Recently, it was shown that the G protein-coupled receptor kinase 2 (GRK2) contains an RGS domain that binds to the active form of G alpha(q). Here, the ability of GRK2 to interact with other members of the G alpha(q) family, G alpha(11), G alpha(14), and G alpha(16), was tested. The signaling of all members of the G alpha(q) family, with the exception of G alpha(16), was inhibited by GRK2. Immunoprecipitation of full-length GRK2 or pull down of GST-GRK2-(45-178) resulted in the detection of G alpha(q), but not G alpha(16), in an activation-dependent manner. Moreover, activated G alpha(16) failed to promote plasma membrane (PM) recruitment of a GRK2-(45-178)-GFP fusion protein. Assays with chimeric G alpha(q)(-)(16) subunits indicated that the C-terminus of G alpha(q) mediates binding to GRK2. Despite showing no interaction with GRK2, G alpha(16) does interact with RGS2, in both inositol phosphate and PM recruitment assays. Thus, GRK2 is the first identified RGS protein that discriminates between members of the G alpha(q) family, while another RGS protein, RGS2, binds to both G alpha(q) and G alpha(16).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885252     DOI: 10.1021/bi034442+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Characterization of the GRK2 binding site of Galphaq.

Authors:  Peter W Day; John J G Tesmer; Rachel Sterne-Marr; Leslie C Freeman; Jeffrey L Benovic; Philip B Wedegaertner
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

Review 2.  Signal activation and inactivation by the Gα helical domain: a long-neglected partner in G protein signaling.

Authors:  Henrik G Dohlman; Janice C Jones
Journal:  Sci Signal       Date:  2012-05-29       Impact factor: 8.192

Review 3.  Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity.

Authors:  Richard T Premont
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  GRK mythology: G-protein receptor kinases in cardiovascular disease.

Authors:  Gerald W Dorn
Journal:  J Mol Med (Berl)       Date:  2009-02-20       Impact factor: 4.599

5.  Regulation of the epithelial Na+ channel by the RH domain of G protein-coupled receptor kinase, GRK2, and Galphaq/11.

Authors:  Il-Ha Lee; Sung-Hee Song; Craig R Campbell; Sharad Kumar; David I Cook; Anuwat Dinudom
Journal:  J Biol Chem       Date:  2011-04-04       Impact factor: 5.157

Review 6.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

7.  The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.

Authors:  Mark E Obrenovich; Hector H Palacios; Eldar Gasimov; Jerzy Leszek; Gjumrakch Aliev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-03

Review 8.  Mechanistic diversity involved in the desensitization of G protein-coupled receptors.

Authors:  Ningning Sun; Kyeong-Man Kim
Journal:  Arch Pharm Res       Date:  2021-03-24       Impact factor: 4.946

Review 9.  Strike a pose: Gαq complexes at the membrane.

Authors:  Angeline M Lyon; Veronica G Taylor; John J G Tesmer
Journal:  Trends Pharmacol Sci       Date:  2013-11-26       Impact factor: 14.819

10.  Evolution of a signaling nexus constrained by protein interfaces and conformational States.

Authors:  Brenda R S Temple; Corbin D Jones; Alan M Jones
Journal:  PLoS Comput Biol       Date:  2010-10-14       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.